未登录

K

Kazunori Tsukuda

Okayama University

H指数:39

被引数:4,588

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Feasibility of Early Laparoscopic Cholecystectomy in High-Risk Acute Cholecystitis: A Critical Evaluation of Tokyo Guidelines 2018 Risk Stratification

高危急性胆囊炎早期腹腔镜胆囊切除术的安全性与可行性：对东京指南2018年风险分层的批判性评估

World Journal of Surgery

IF2.5

2026-07-010

PRE

Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naive lung adenocarcinoma

IF3.4

2019-02-262

OAAI

Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR

IF2.9

2018-03-1323

OAAI

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma

IF6.4

2018-01-2412

OAAI

Multiple acquired resistance mechanisms against third generation EGFR-TKI osimeritinib in non-smal cell lung cancer cells

CANCER RESEARCH

IF16.6

2017-07-011

PRE

Antitumor effect of LRIG1, negative regulator of ErbB, in lung cancer harboring mutant-EGFR

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Antitumor activity of multikinase inhibitors in HER2-positive gastric cancer cells

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system

ONCOLOGY REPORTS

IF3.9

2017-04-1115

OAAI

Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features

SCIENTIFIC REPORTS

IF3.9

2017-01-1353

OAAI

Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway

SCIENTIFIC REPORTS

IF3.9

2016-12-2323

OAAI

Detection of EGFR mutations in circulating cell-free DNA of non-small cell lung cancer patients by next-generation sequencing

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Yesl is the key molecule for the resistance to trastuzumab in breast cancer, and dasatinib overcomes the resistance

CANCER RESEARCH

IF16.6

2016-07-151

PRE

Anti-tumor effect of Dasatinib in HER2 positive breast cancer with Trastuzumab resistance

CANCER RESEARCH

IF16.6

2015-08-012

PRE

Effect of Hsp90 inhibitor NVP-AUY922 with radiation on lung adenocarcinoma cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Non-invasive EGFR T790M detection using droplet digital PCR system

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Identification of a novel binding protein playing a critical role in HER2 activation in lung cancer cells

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Anti-tumor effect of afatinib, an irreversible EGFR/HER2 dual inhibitor, in lung cancers harboring HER2 oncogene

CANCER RESEARCH

IF16.6

2015-08-010

PRE

The role of GDF-15 on docetaxel resistance in lung cancer

CANCER RESEARCH

IF16.6

2015-08-011

PRE

Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

ONCOLOGY REPORTS

IF3.9

2015-01-2018

OA

The molecular characters of acquired resistant non-small cell lung cancer cells to afatinib

CANCER RESEARCH

IF16.6

2014-10-010

PRE